Ever bought medicines or cosmetics over the counter? Yes, then you may have walked into one of the 7,700 retail CVS/pharmacy stores of the largest pharmacy healthcare services provider in the U.S. – CVS Health Corporation (CVS – Analyst Report). This Rhode Island-based company’s more than 900 walk-in medical clinics-CVS/MinuteClinic currently possess a customer satisfaction rate of 95%.

Currently, CVS Health has a Zacks Rank #3 (Hold) but that could change following its strong fourth-quarter and full-year 2015 earnings report which has just released. We have highlighted some of the key details from the just-released announcement below:

Earnings: The Zacks Consensus Estimate remained steady at $1.53 per share over the last 60 days. CVS Health’s adjusted earnings per share of $1.53 came in line with this estimate.

Revenues: CVS Health posted revenues of $41.145 billion, beating the Zacks Consensus Estimate for revenues of $41.016 billion.

Key Stats: CVS Health’s Pharmacy Services segment revenues increased 11.1% to $26.5 billion, while revenues from Retail/LTC segment improved 12.5% year over year to $19.9 billion. During the fourth quarter, CVS Health opened 53 new retail drugstores, acquired 1,672 pharmacies and closed 14 retail stores. Further, the company relocated 19 retail drugstores.

Major Factors: During 2015, CVS Health made two significant investments. On one hand, the company expanded its core business with the acquisition of Target’s pharmacies and clinics, while on the other hand enhanced its reach with the acquisition of Omnicare, the leader in long-term care pharmacy. CVS Health also generated better-than-expected free cash flow of $6.4 billion for the full-year 2015. The company also delivered strong performance in the fourth quarter, accompanied by in-line top and bottom-line results.

Stock Price: Following the earnings release, share prices did not show any movement in the pre-market trading session.